Is acute myeloid leukemia treatment possible without transplant?

Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.

What is the AML transplant success rate?

With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.

How long does acute myeloid leukemia (AML) treatment take?

Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.

How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?

AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib

What is acute myeloid leukemia (AML) remission treatment?

It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.

Is acute myeloid leukemia (AML) common in India?

Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.

Can children get AML?

Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.

What is acute lymphocytic leukemia (ALL)?

ALL is a fast-growing cancer of the bone marrow and blood that affects lymphoid precursor cells. It occurs in both children and adults and requires immediate, specialized treatment.

What are the early symptoms of Acute Lymphocytic Leukemia (ALL)

Common symptoms include fatigue, infections, bruising or bleeding, bone pain, and swollen lymph nodes. Prompt diagnosis is essential.

How is ALL diagnosed at BMT Next?

We use CBC, bone marrow biopsy, flow cytometry, cytogenetics (e.g., BCR-ABL1), MRD testing, and next-generation sequencing to confirm the diagnosis and subtype.

What is the success rate for pediatric Acute Lymphocytic Leukemia (ALL) at BMT Next?

In standard-risk pediatric ALL, our survival rates exceed 94%, aligning with top international benchmarks.

What is the role of bone marrow transplant in ALL?

BMT is offered to patients with high-risk features, poor response to induction therapy, relapsed disease, or specific cytogenetic abnormalities like Ph+ ALL.

Can adults with ALL also be treated at BMT Next?

Yes. We treat adult ALL using age-adapted protocols and offer reduced-intensity transplant regimens when needed.

What targeted therapies do you offer for relapsed or refractory Acute Lymphocytic Leukemia (ALL)?

We provide access to Blinatumomab (BiTE), Inotuzumab ozogamicin, and TKIs for Ph+ ALL. CAR-T therapy is coordinated with leading centers in India.

How does BMT Next support international patients from Mauritius or Africa?

We offer virtual consultations, visa and travel assistance, multilingual care coordination, and continuity of treatment between India and Mauritius.

Is CAR-T cell therapy available for Acute Lymphocytic Leukemia (ALL)at BMT Next?

Yes. We collaborate with accredited CAR-T therapy partners to treat CD19+ relapsed/refractory ALL cases.

How is MRD testing used to guide treatment?

MRD (Minimal Residual Disease) testing after induction and consolidation phases helps assess treatment effectiveness and guides the need for BMT.

What are the side effects of chemotherapy for Acute Lymphocytic Leukemia (ALL)?

Side effects include neutropenia, infections, nausea, hair loss, and fatigue. We manage toxicity through supportive care and growth factor use.

Do you provide fertility preservation for young ALL patients?

Yes. We offer fertility counseling and options like sperm banking and ovarian tissue preservation before intensive chemotherapy or transplant.

How long is treatment for acute lymphocytic leukemia?

Pediatric ALL treatment typically lasts 2–3 years. Adult protocols are shorter but may include transplant or advanced therapies.

What makes BMT Next different from other leukemia centers?

We provide MRD-guided treatment, access to immunotherapy and transplant, global referrals, and unmatched survival outcomes in India.

How can I book a second opinion at BMT Next?

You can request a virtual or in-person second opinion by sharing your reports through our patient portal or contacting our coordination team directly.

Why is BMT Next considered the best center for acute lymphocytic leukemia (ALL) treatment in Gurgaon (Gurugram)?

BMT Next in Gurgaon is equipped with advanced genomic testing, CAR-T therapy access, expert-led transplant services, and participation in international clinical trials. It offers personalized care for both pediatric and adult ALL patients, combining technology, experience, and outcomes that meet global standards.

Best Multiple Myeloma Treatment in India

Services

let us helping you by make an appointment

Lorem ipsum dolor sit amet consectetur.

Top Center for Multiple Myeloma Treatment

BMT Next delivers the best multiple myeloma treatment in India, offering evidence-based and research-driven protocols across all our locations in Gurgaon (Gurugram), Hisar, Faridabad, and internationally through our dedicated unit for Mauritius. Patients trust us for not only our outcomes but also our deep commitment to ethical, patient-focused care.

Our facilities feature highly experienced hematologists, state-of-the-art transplant units, and infection-controlled chemotherapy suites. We focus on integrating autologous stem cell transplant (ASCT), CAR-T therapy, BiTE therapy, and maintenance strategies using lenalidomide and thalidomide to ensure durable remissions in all subtypes of plasma cell cancer. The holistic care we provide includes psychosocial support, pain management, renal support, and long-term rehabilitation. We are a team of best bone marrow transplant specialists.

Understanding Multiple Myeloma: Causes, Risk Factors, and Disease Progression

Multiple myeloma is a hematologic malignancy that originates from plasma cells and disrupts normal blood formation. It can cause severe bone damage, kidney failure, and life-threatening infections. Genetic abnormalities like del(17p) and t(4;14) increase risk and influence prognosis. Environmental exposure to radiation, industrial chemicals, and obesity are also significant contributors to disease onset.

BMT Next incorporates MRD testing, FISH cytogenetics, and regular PET-CT screening to detect disease at early and advanced stages. We actively monitor high-risk individuals such as those with MGUS and smoldering myeloma, allowing for early intervention and improved long-term survival. Trust the best multiple myeloma treatment center in Gurgaon, Hisar, Faridabad and Mauritius.

Signs & Symptoms: When to Consult a Multiple Myeloma Specialist

Patients who experience persistent, unexplained bone pain, repeated infections, fatigue, or symptoms of renal failure may be developing multiple myeloma. Other signs include fractures from minor injuries, frequent fevers, and high calcium levels causing confusion or constipation. At BMT Next, our best hematologists in Gurgaon, Hisar, and Faridabad offer prompt evaluation to initiate immediate diagnostic testing and treatment. We prioritize rapid workup for suspected plasma cell cancer to minimize disease progression. We esnure zero delay, trust us for best multiple myeloma treatment in India and Mauritius.

Types and Staging of Multiple Myeloma

BMT Next treats all stages of multiple myeloma, from asymptomatic forms to aggressive relapsed disease. Smoldering myeloma patients undergo close surveillance through light chain assays and bone marrow biopsies. Active myeloma is managed with combinations like VRD or Dara-VRD, followed by autologous stem cell transplant for eligible individuals.

Diagnosis at India’s Best Multiple Myeloma Center

Accurate diagnosis is the first step toward delivering the best multiple myeloma treatment in India. At BMT Next, we offer comprehensive diagnostic services that ensure precise staging, risk stratification, and therapy planning. Each patient undergoes an extensive evaluation process at our centers in Gurgaon, Hisar, Faridabad, and for international patients from Mauritius and other countries. This includes a full clinical assessment, imaging, laboratory evaluation, and cytogenetic profiling to define the subtype and aggressiveness of the disease. We have provided remarkable results across India. Trust the best multiple myeloma treatment center in gurgaon.

Best Multiple Myeloma Treatment & Diagnostic Infrastructure

Diagnostic precision defines success in myeloma treatment. At BMT Next, we perform in-house:

Bone marrow aspiration and biopsy with immunophenotyping
SPEP, IFE, and free light chain testing for monitoring protein levels
Whole-body PET-CT scans and MRI spine imaging for detecting bone lesions
FISH cytogenetics to identify chromosomal abnormalities like del(13q), t(11;14), and gain of 1q
MRD testing using flow cytometry and NGS for minimal disease tracking after therapy

Meet Our Multiple Myeloma Specialists at BMT Next

At BMT Next, expert-led care is the foundation of our reputation. Our experts bring years of focused experience in multiple myeloma diagnosis, bone marrow transplant, and advanced immunotherapy in India.

Dr. Meet Kumar (MD, DM Hematology) leads our myeloma transplant center with more than 20 years of experience in treating complex hematologic malignancies. Dr. Neeraj Teotia is recognized for his expertise in FISH cytogenetics and tailoring therapy for high-risk multiple myeloma patients in India. Dr. Umesh Yadav focuses on supportive care protocols, MRD-based monitoring, and long-term survivorship in myeloma patients. Dr. Sumit Joshi, with over 14 years in hemato-oncology and critical care, brings expertise in managing aplastic anemia, leukemia, and post-transplant complications, and is instrumental in coordinating comprehensive care for adult and pediatric myeloma patients.

Together, this multidisciplinary team collaborates to deliver precision medicine through the lens of global guidelines, ensuring patients receive the best myeloma treatment in Gurgaon, Hisar, Faridabad, and internationally in Mauritius.

Best Multiple Myeloma Treatment Options at BMT Next

Our treatment strategies vary based on disease stage, patient performance status, and cytogenetic risk.

Initial therapy typically includes triplet or quadruplet drug combinations such as VRD, KRD, or Daratumumab-VRD. Following induction, ASCT is the standard for eligible patients. For those ineligible for transplant, long-term oral chemotherapy protocols with Ixazomib, Lenalidomide, or Thalidomide are used.

Patients with relapsed or refractory myeloma are offered innovative options such as CAR-T therapy, BiTE therapy, or newer immunomodulatory and proteasome inhibitors. Maintenance therapy with Lenalidomide or Ixazomib is tailored using MRD results, ensuring precision dosing and minimizing toxicity. Every patient also receives supportive interventions such as bone-strengthening agents, erythropoiesis stimulants, and nephrology input. We are an expert team of Multiple Myeloma Treatment in Gurgaon, Hisar, Faridabad and Mauritius.

Best Multiple Myeloma Treatment Across India

BMT Next offers the best multiple myeloma treatment in India across all our centers with equally advanced, high-quality care. Our Gurgaon center is internationally recognized for excellence in bone marrow transplant, CAR-T cell therapy, and high-risk myeloma management. It is fully equipped with HEPA-filtered BMT units, MRD monitoring, and advanced diagnostic labs. Choose the best multiple myeloma treatment center in Gurgaon!

Our Hisar center delivers the best multiple myeloma treatment in Hisar, offering the same diagnostic accuracy, chemotherapy regimens, and hematologist-led care. It ensures patients in Haryana and nearby regions have access to cutting-edge therapy protocols and transplant referrals without having to travel far.

At our Faridabad center, we provide the best multiple myeloma treatment in Faridabad, with a strong focus on personalized follow-up, imaging support, and rehabilitation care for patients undergoing or recovering from treatment. Our experts here manage relapsed, elderly, and comorbid patients with precision.

For our international patients, the Mauritius coordination desk ensures full access to the best multiple myeloma treatment in India. Patients from Mauritius and the Indian Ocean region receive direct support for travel, interpreter services, scheduling, and remote follow-up. They are treated on par with domestic patients, with equal access to CAR-T, BiTE, and ASCT therapies offered across all BMT Next centers.

Need Help?

FAQs

What is multiple myeloma and how is it different from other blood cancers?

Multiple myeloma is considered a cancer of plasma cells, a type of white blood cell that helps fight infection. Unlike leukemia or lymphoma, it majorly affects the bone marrow and skeletal system.

What are the early signs of multiple myeloma?

Early signs include persistent bone pain, frequent infections, unexplained fatigue, anemia, kidney dysfunction, and high calcium levels.

How is multiple myeloma diagnosed at BMT Next?

We use a combination of blood tests (SPEP, IFE, FLC), bone marrow biopsy, PET-CT or MRI, and FISH cytogenetic studies to confirm diagnosis and risk stratify the disease.

What is the role of FISH cytogenetics in myeloma diagnosis?

FISH identifies genetic abnormalities like del(17p), t(4;14), or 1q gain, which help us predict prognosis and customize treatment.

Is bone marrow transplant mandatory for all myeloma patients?

No. Autologous stem cell transplant (ASCT) is recommended for eligible patients to prolong remission, but alternatives exist for transplant-ineligible individuals.

What is CAR-T therapy and is it available at BMT Next?

CAR-T therapy involves genetically modifying a patient’s own T-cells to fight myeloma. It is available through clinical access programs at BMT Next.

. What are the treatment options for relapsed or refractory myeloma?

Options include immunomodulators like Pomalidomide, monoclonal antibodies like Daratumumab, BiTE therapies, and CAR-T cells.

How does BMT Next monitor treatment response?

We use MRD (minimal residual disease) testing via flow cytometry or NGS to monitor the depth of remission after treatment.

Are there different types of multiple myeloma?

Yes, including smoldering myeloma (asymptomatic), active myeloma (requiring treatment), and relapsed/refractory myeloma.

What support services are offered at BMT Next for myeloma patients?

Patients receive nutritional counseling, pain management, physiotherapy, renal care, and emotional wellness support throughout treatment.

What makes BMT Next the best center for multiple myeloma treatment in India?

BMT Next offers the best multiple myeloma treatment in India through its expert-led centers in Gurgaon, Hisar, Faridabad, and Mauritius. Our strength lies in bone marrow transplant excellence, MRD-based treatment, next-level FISH cytogenetics, and access to CAR-T and BiTE therapy. Patients across North India and internationally choose BMT Next for high-quality, affordable, and personalized plasma cell cancer treatment.